Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Who owns the rights to PrEP? The U.S. government or the pharma giant?
A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.
The Trump administration’s efforts to ban service members who have HIV are not based on current science, the judge stated.
But that doesn’t mean the Affordable Care Act is safe. Here’s what’s up next.
Health officials with Goshen Hospital in Indiana called the risk of infection “extremely low.”
The courts will be the judge of that. And AIDS United welcomes the lawsuit over Truvada as HIV prevention.
To be clear: You can’t get HIV by eating food handled by someone who is positive.
The complaint alleges the company has profited from research spearheaded by the CDC.
“We will not be able to provide you with a service because you need a doctor’s consent.”
Class action lawsuit challenges deals that limit generic drug competition; Gilead says the case is without merit.
Two HIV lawsuits challenging Pentagon policy will go to trial next month. A third is on its way.
The court case could eliminate protections for people with pre-existing conditions. Plus 20 million Americans could lose their insurance.
The 2018 discrimination lawsuit led Lambda Legal and the Black AIDS Institute to launch the “Cut the Stigma” campaign. [VIDEO]
Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.